The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. AbCellera Biologics Inc. (ABCL) is a stock that can certainly ...

Recent discussions on X about AbCellera Biologics (ABCL) have been buzzing with excitement following a significant surge in the stock price, with some posts noting a jump of over 25% in a single day.

ABCL635 is being developed as a non-hormonal treatment for menopause-related vasomotor symptoms such as hot flashes. ・ABCL is pivoting to become a fully integrated clinical-stage biotech that develops ...

AbCellera Biologics Inc. ( NASDAQ:ABCL ) defied analyst predictions to release its quarterly results, which were ...

Holdings Ltd. Thermopylae, a 10% owner of $ABCL, bought 343,631 shares of the company on 03-11-2025 for an estimated $742,242. This trade was reported by Quiver ...

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc. (ABCL)’s share ...

We recently compiled a list of the 10 Best Multibagger Penny Stocks of 2025. In this article, we are going to take a look at where AbCellera Biologics Inc. (NASDAQ:ABCL) stands against the other ...

In recent days, attention has centred on AbCellera Biologics ahead of its upcoming Q1 earnings call and the May 11, 2026 Phase 1 interim data update for ABCL635, a clinical candidate targeting ...